Press News

Press News

Press News | 24.09.2025

Print:
Title Media Publ. Date
Joint position of EFEX and EOF on the non-correlation of the substance Kathimerini 24/09/2025
Joint stance of EFEX and EOF on the non-association of the substance Naftemporiki 24/09/2025
“Tsunami” in markets and stakeholder reactions following Trump’s diagnosis Naftemporiki 24/09/2025
No connection between paracetamol and autism Ta Nea 24/09/2025

 

See here the publicity

 

Web Monitoring Report for the period 23/09 – 24/09

Title Media Publ. Date
The draft bill of the MoH, addressing matters from hospital staffing to pharmaceutical expenditure, has been released for public consultation as of today amna.gr 24/09/2025
EOF: No change in recommendations regarding paracetamol use during pregnancy cnn.gr 23/09/2025
MoH: Directive to establish new operational structures in all hospitals across the country – How employees and departments are affected healthreport.gr 24/09/2025
Georgiadis: Emergency grant from the Ministry of Finance for outstanding debts iatronet.gr 24/09/2025
A challenge for the EU: Which medicines are in short supply in Europe? in.gr 24/09/2025
A bill on new health technologies will be brought before Parliament in October in.gr 24/09/2025
VIANEX: Extroversion and investment in new products despite the pressures of the clawback newmoney.gr 24/09/2025
Georgiadis: There is no study in Europe linking paracetamol use during pregnancy to autism news4health.gr 24/09/2025
Health Technology Assessment: The first key reforms are set to be voted on in Parliament in October news4health.gr 23/09/2025
Comprehensive bill introducing over 100 changes in the healthcare sector tovima.gr 24/09/2025
Adonis Georgiadis has urged hospital administrators to remain constantly vigilant and readily accessible by phone ygeiamou.gr 24/09/2025

RELATED NEWS

Skip to content
SFEE
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.